☆ 4.6 Review

Lymphomas in sub-Saharan Africa - what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

BRITISH JOURNAL OF HAEMATOLOGY (2011)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 154, Issue 6, Pages 696-703

Publisher

WILEY

DOI: 10.1111/j.1365-2141.2011.08772.x

Keywords

lymphomas; malignant haematology; epidemiology

Categories

Hematology

Funding

office of HIV and AIDS malignancy, National Cancer Institute, USA

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Approximately 30 000 cases of non-Hodgkin lymphoma (NHL) occur in the equatorial belt of Africa each year. Apart from the fact that Burkitt lymphoma (BL) is very common among children and adolescents in Africa and that an epidemic of human immunodeficiency virus (HIV) infection is currently ongoing in this part of the world, very little is known about lymphomas in Africa. This review provides information regarding the current infrastructure for diagnostics in sub-Saharan Africa. The results on the diagnostic accuracy and on the distribution of different lymphoma subsets in sub-Saharan Africa were based on a review undertaken by a team of lymphoma experts on 159 fine needle aspirate samples and 467 histological samples during their visit to selected sub-Saharan African centres is presented. Among children (<18 years of age), BL accounted for 82% of all NHL, and among adults, diffuse large B-cell lymphoma accounted for 55% of all NHLs. Among adults, various lymphomas other than BL, including T-cell lymphomas, were encountered. The review also discusses the current strategies of the International Network of Cancer Treatment and Research on improving the diagnostic standards and management of lymphoma patients and in acquiring reliable clinical and pathology data in sub-Saharan Africa for fostering high-quality translational research.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Medicine, General & Internal

Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes

Vanessa F. Bratti, Brooke E. Wilson, Rouhi Fazelzad, Aliyah Pabani, Shalini J. Zurn, Sonali Johnson, Lillian Sung, Danielle Rodin

Summary: Antimicrobial resistance (AMR) is a global public health concern, especially in cancer patients who have a higher risk of infection due to their immunosuppressive nature of treatment. This scoping review aims to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship and minimize the detrimental effects on cancer outcomes.

BMJ OPEN (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases

Youxi Yu, Xiaoju Shi, Xingtong Wang, Ping Zhang, Ou Bai, Yan Li

Summary: Recent studies have found a strong association between metabolic disorders and the development of lymphomas. It has also been observed that some solid tumor survivors may develop secondary lymphomas, while some lymphoma survivors might develop a second malignant neoplasm.

CELL AND BIOSCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Characteristics and survival of patients with cancer with intended off-label use-a cohort study

Andreas Michael Schmitt, Martin Walter, Amanda Katherina Herbrand, Markus Joerger, Giusi Moffa, Urban Novak, Lars Hemkens, Benjamin Kasenda

Summary: This study described the characteristics and survival of patients with cancer who had intended off-label use (OLU) cancer treatment and reimbursement request. The results showed that patients with access to intended OLU were younger, had better overall prognosis, less frequently had solid cancer, were in earlier stages, and had longer median overall survival compared to patients without access.

BMJ OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Symptoms of acute transfusion reactions at a general referral hospital in Kinshasa, Democratic Republic of Congo: a cross-sectional study

Patou Masika Musumari, Samclide Mutindu Mbikayi, Kriengkrai Srithanaviboonchai, Teeranee Techasrivichien, Arunrat Tangmunkongvorakul, Leon Tshilolo

Summary: Blood transfusion is a life-saving procedure with associated risks, including acute transfusion reactions (ATRs). This study in the DRC documented a 2.6% prevalence of ATRs in blood transfusion recipients, with common symptoms being dyspnea, fever, and rash/hives. The study emphasizes the need for surveillance to detect, prevent, and manage ATRs in this context.

BMJ OPEN (2021)

Add to Collection

Review Oncology

Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas

Tomas Etrych, Alena Braunova, David Zogala, Lukas Lambert, Nicol Renesova, Pavel Klener

Summary: Targeted drug delivery (TDD) is an innovative and effective treatment approach that aims to minimize damage to healthy tissues. Current TDD modalities include radioimmunotherapy (RIT), antibody-drug conjugates (ADC), and new formulations based on the enhanced permeability and retention effect. Diagnostic and restaging procedures in aggressive lymphomas are based on nuclear imaging, and a theranostic approach that combines diagnostic imaging with targeted treatment is an appealing strategy in personalized medicine.

CANCERS (2022)

Add to Collection

Article Hematology

Infection with Neoehrlichia mikurensis promotes the development of malignant B- cell lymphomas

Christine Wenneras, Alaitz Aranburu, Linda Wass, Anna Grankvist, Anna Staffas, Anastasia Soboli, Inga-Lill Martensson, Linda Fogelstrand, Catharina Lewerin

Summary: In this investigation of 5 patients with malignant B-cell lymphoma and concomitant N. mikurensis infection, it was found that chronic stimulation of B cells may lead to B-cell transformation and lymphoma. In some cases, significant improvement and cessation of lymphoma treatment were observed after elimination of N. mikurensis.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Biotechnology & Applied Microbiology

circMRPS35 promotes malignant progression and cisplatin resistance in carcinoma

Peng Li, Runjie Song, Fan Yin, Mei Liu, Huijiao Liu, Shuoqian Ma, Xiaomeng Jia, Xiaohui Lu, Yuting Zhong, Lei Yu, Xiru Li, Xiangdong Li

Summary: This study identifies circMRPS35 as a highly expressed circRNA in HCC and shows that its knockdown inhibits cell proliferation, migration, invasion, and colony formation, as well as tumor growth. circMRPS35 regulates PTEN expression and degradation through miR-148a and STX3. Additionally, the circMRPS35-encoded peptide circMRPS35-168aa promotes cisplatin resistance in HCC.

MOLECULAR THERAPY (2022)

Add to Collection

Review Oncology

Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma

Fraser Brims

Summary: Mesothelioma is a cancer of the lining of the lungs caused by breathing in asbestos fibres, which remains a challenge in terms of treatment and has an uncertain survival time. The disease mainly occurs in males, with a clear risk associated with exposure to asbestos. There have been significant advances in diagnosis, but further research and treatment are still needed.

CANCERS (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study

Joel G. Ray, Alison L. Park

Summary: This study compared outcomes between different blood types and different vaccine types for SARS-CoV-2 infection and severe COVID-19, showing that vaccination can reduce the risk of infection and disease. After receiving the first dose of mRNA or Ad-V vaccine, the risk of infection decreased, as did the risk of severe COVID-19.

BMJ OPEN (2022)

Add to Collection

Article Oncology

Age and Cohort Trends of Malignant Melanoma in the United States

Stephanie G. Lashway, Robin B. Harris, Leslie Farland, Mary Kay O'Rourke, Leslie K. Dennis

Summary: The incidence of malignant melanoma in the United States is increasing over time, possibly due to changes in ultraviolet radiation exposure, lifestyle factors, or increased awareness and diagnosis. Recent birth cohorts may experience higher rates of melanoma as they age. The increase in thin melanomas is a significant factor driving the overall rise in malignant melanoma cases.

CANCERS (2021)

Add to Collection

Review Immunology

Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities

Baptiste Brauge, Elise Dessauge, Florent Creusat, Karin Tarte

Summary: B-cell lymphomas are heterogeneous neoplasms resulting from the clonal expansion of mature B cells. The tumor microenvironment plays a crucial role in lymphomagenesis and treatment resistance, but many questions regarding the mechanisms and potential therapeutic opportunities remain unanswered.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Hematology

A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia

Thomas Coats, Daniel Bean, Aymeric Basset, Tamir Sirkis, Jonathan Brammeld, Sean Johnson, Ian Thomas, Amanda Gilkes, Kavita Raj, Mike Dennis, Steve Knapper, Priyanka Mehta, Asim Khwaja, Hannah Hunter, Sudhir Tauro, David Bowen, Gail Jones, Richard Dobson, Nigel Russell, Richard Dillon

Summary: This study combined drug eligibility criteria and genetic risk stratification into a digital format to define various treatment eligibility scenarios, and successfully generated a consensus AML induction treatment in 98% of cases using this novel approach.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Oncology

Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study

Antoine Jaquet, Simon P. Boni, Kouakou Boidy, Judicael Tine, Boris Tchounga, Sokhna A. Toure, Jean-Jacques Koffi, Cherif Dial, Alain Monnereau, Isidore Diomande, Aristophane Tanon, Moussa Seydi, Francois Dabis, Saliou Diop, Gustave Koffi

Summary: The study found that Non-Hodgkin lymphomas in West Africa are mainly influenced by chronic viral hepatitis and HIV infection, with HBV, HCV, and HIV viruses independently associated with NHL.

INTERNATIONAL JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation

Kazuya Sato, Sho Igarashi, Nodoka Tsukada, Junki Inamura, Masayo Yamamoto, Motohiro Shindo, Kentaro Moriichi, Yusuke Mizukami, Mikihiro Fujiya, Yoshihiro Torimoto

Summary: This study aimed to evaluate the incidence and risk factors of cytomegalovirus infection in patients with malignant lymphoma who did not receive hematopoietic stem cell transplantation. The study found that pretreatment with steroids and multiple therapeutic regimens were independent risk factors for cytomegalovirus infection in these patients.

BMC CANCER (2022)

Add to Collection

Article Oncology

Epidemiological Study of Malignant Paediatric Liver Tumours in Denmark 1985-2020

Thomas N. N. Nissen, Catherine Rechnitzer, Birgitte K. K. Albertsen, Lotte Borgwardt, Vibeke B. B. Christensen, Eva Fallentin, Henrik Hasle, Lars S. S. Johansen, Lisa L. L. Maroun, Karin B. B. Nissen, Allan Rasmussen, Mathias Rathe, Steen Rosthoj, Nicolai A. A. Schultz, Peder S. S. Wehner, Marianne H. H. Jorgensen, Jesper Brok

Summary: This study reports the incidence, outcomes, and long-term adverse events of malignant liver tumors in Danish children over the past 35 years. The overall incidence of liver tumors in Danish children was approximately 2.29 per 1 million children per year, with hepatoblastoma being the most common tumor. The overall 5-year survival rate was 84% and 78% for hepatoblastomas and hepatocellular carcinomas, respectively, with age≥8 years being the most significant factor associated with a poorer prognosis. Adverse events included reduced renal and cardiac function, as well as impaired hearing function, affecting a significant number of patients.

CANCERS (2023)

Add to Collection

Article Cell Biology

Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression

Massimo Granai, Stefano Lazzi, Virginia Mancini, Ayse Akarca, Raffaella Santi, Federica Vergoni, Ester Sorrentino, Raffaella Guazzo, Lucia Mundo, Gabriele Cevenini, Claudio Tripodo, Gioia Di Stefano, Benedetta Puccini, Maurilio Ponzoni, Elena Sabattini, Claudio Agostinelli, Nuray Bassullu, Tulay Tecimer, Ahu Senem Demiroz, Leah Mnango, Stephan Dirnhofer, Leticia Quintanilla-Martinez, Teresa Marafioti, Falko Fend, Lorenzo Leoncini

Summary: This study provides insights into the immune cell subsets involved in the early phase of Burkitt lymphoma, which may help in maintaining the tumor in a self-limited state or inducing its regression. These findings may open up new potential therapeutic avenues for EBV-positive BL patients in the era of cellular immunotherapy.

HISTOPATHOLOGY (2022)

Add to Collection

Letter Cell Biology

A refined approach to the diagnosis of Burkitt lymphoma in a resource-poor setting

Kikkeri N. Naresh, Stefano Lazzi, Raffaella Santi, Massimo Granai, Noel Onyango, Lorenzo Leoncini

HISTOPATHOLOGY (2022)

Add to Collection

Article Oncology

Blasts in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward?

Xueyan Chen, Jonathan R. Fromm, Kikkeri N. Naresh

LEUKEMIA (2022)

Add to Collection

Article Pathology

Variant histology in nodular lymphocyte predominant Hodgkin lymphoma in an adult population: disease investigations and characteristics from a retrospective cohort

Arthur Stacey, Alexandra Jane Marks, Kikkeri N. Naresh

Summary: A subset of nodular lymphocyte-predominant Hodgkin lymphoma patients have variant histological patterns, which are associated with advanced disease stage and increased recurrence risk. Analysis of histopathology reports from 33 adult patients revealed that 39% had variant histology. Variant histology was significantly associated with stage IV disease.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Add to Collection

Article Hematology

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon Barrans, Suzan van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon Rule, Nicola Crosbie, Andrew Clear, Maria Calaminici, Hendrik Runge, Robert K. Hills, David W. Scott, Lisa M. Rimsza, Geetha Menon, Chulin Sha, John R. Davies, Ai Nagano, Andrew Davies, Daniel Painter, Alexandra Smith, John Gribben, Kikkeri N. Naresh, David R. Westhead, Jessica Okosun, Andrew Steele, Daniel J. Hodson, Sriram Balasubramanian, Peter Johnson, Jun Wang, Jude Fitzgibbon

Summary: Despite the effectiveness of immuno-chemotherapy, there is a significant rate of relapse or refractory disease in patients with DLBCL. Our study focuses on the changes in gene expression profiles (GEP) that accompany DLBCL relapse, and we have developed a 30-gene discriminator that can identify clinically distinct high and low-risk subgroups in DLBCL patients. This signature has also been found to predict better outcomes in patients treated with ibrutinib-R-CHOP.

BLOOD ADVANCES (2023)

Add to Collection

Article Pathology

Predictors of risk of relapse in classic Hodgkin lymphoma

Jonathan R. Fromm, Claire Tang, Kikkeri N. Naresh

Summary: Using flow cytometric analysis, it was found that the percentage of HRS cells is associated with treatment response and patient age, and the subtype also affects the proportion of B cells.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Add to Collection

Letter Hematology

Aleukemic mast cell leukemia, well-differentiated and chronic type

Kenneth Chen, Paul C. C. Hendrie, Kikkeri N. N. Naresh

ANNALS OF HEMATOLOGY (2023)

Add to Collection

Article Oncology

Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics

Shahin Sayed, Hela Koka, Mustapha Abubakar, Kevin Gardner, Roberto Salgado, Zahir Moloo, Ambar Beatriz Caban-Urena, Daniel Rosen, Patricia Castro, Mansoor Saleh, Asim Jamal Shaikh, Jasmit Shah, Jonine Figueroa, Francis Makokha, Hien Khanh Ha, Zhong Wang, Pumza Magangane, Richard Naidoo, Veronica Ngundo, Xiaohong Rose Yang, Dhirendra Govender

Summary: This study aimed to describe the distribution of Tumour Infiltrating Lymphocytes (TILs) in the intratumoural stroma (sTILs) and the leading/invasive edge stroma (LE-TILs) in breast cancer patients from Kenya, and evaluate TILs across breast cancer subtypes with established risk factors and clinical characteristics. The results showed that TILs were enriched in more aggressive breast cancers, and the associations of sTILs/LE-TILs measures with examined factors varied.

BREAST CANCER RESEARCH AND TREATMENT (2023)

Add to Collection

Letter Oncology

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Dima El-Sharkawi, Amit Sud, Catherine Prodger, Jahanzaib Khwaja, Rohan Shotton, Brian Hanley, Victoria Peacock, Ying Ying Peng, Anita Arasaretnam, Sarkhara Sharma, Frances Aldridge, Bhupinder Sharma, Andrew Wotherspoon, Betty Cheung, Corinne De Lord, Rosalynd Johnston, Shireen Kassam, Ruth Pettengel, Kim Linton, Paul Greaves, Lucy Cook, Kikkeri N. Naresh, Kate Cwynarski, Toby A. Eyre, Ian Chau, David Cunningham, Sunil Iyengar

BLOOD CANCER JOURNAL (2023)

Add to Collection

Article Hematology

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Adam S. Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin H. Karimi, Narendranath Epperla, David A. Bond, Umar Farooq, Mahak Saad, Andrew M. Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley Haverkos, Reem Karmali, Timothy S. Oh, Julie M. Vose, Heather Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J. Olszewski

Summary: In this retrospective study, 160 patients with high-grade B-cell lymphoma, not otherwise specified (HGBL-NOS), were examined to determine their characteristics and outcomes. The study found that HG BL-NOS tumors are heterogeneous and most patients presented with advanced stage disease and high-risk clinical factors. Poor performance status, high lactate dehydrogenase, and a dual-expressor immunophenotype were identified as main prognostic factors for progression-free survival and overall survival.

BLOOD ADVANCES (2023)

Add to Collection

Editorial Material Hematology

T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation

Alireza Torabi, Kikkeri N. Naresh

BLOOD (2023)

Add to Collection

Article Hematology

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor-T cell therapy

Cecilia C. S. Yeung, David W. Woolston, Vicky Wu, Jenna M. Voutsinas, Ryan Basom, Chris Davis, Alexandre V. Hirayama, Kikkeri N. Naresh

Summary: This study retrospectively observed bone marrow abnormalities in 259 patients receiving CAR-T cell immunotherapy. The study found that 25.5% of patients showed severe marrow hypocellularity and 6.2% showed serous atrophy at a median of 35.5 days post-infusion. Additionally, the study found correlations between bone marrow pathology findings and disease burden and survival rates.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Pathology

Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms

Xueyan Chen, Wenjing Wang, Jeffrey Yeh, Yu Wu, Vivian G. Oehler, Kikkeri N. Naresh, Yajuan J. Liu

Summary: This study validated the use of FusionPlex Pan-Heme panel analysis for routine clinical testing, which can sensitively and rapidly identify a wide range of gene fusions for precise diagnosis and prognostication. The validation results showed good concordance between the FusionPlex panel and other methods. In an independent cohort, this analysis reliably detected gene fusions, contributing to accurate classification of hematologic neoplasms and discovery of new fusion partners.

JOURNAL OF MOLECULAR DIAGNOSTICS (2023)

Add to Collection

Correction Oncology

The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee-Joo Chng, John K. Choi, Shih-Sung Chuang, Sarah E. Coupland, Magdalena Czader, Sandeep S. Dave, Daphne de Jong, Arianna Di Napoli, Ming-Qing Du, Kojo S. Elenitoba-Johnson, Judith Ferry, Julia Geyer, Dita Gratzinger, Joan Guitart, Sumeet Gujral, Marian Harris, Christine J. Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph Khoury, Hiroshi Kimura, Wolfram Klapper, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao-Qiu Li, Megan S. Lim, Wei-Ping Liu, Abner Louissaint, Andrea Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes-Moreno, William Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok-Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andrew C. Rawstron, Karen Rech, Andreas Rosenwald, Jonathan Said, Clementine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William Sewell, Reiner Siebert, Aliyah R. Sohani, Ritsuro Suzuki, Reuben Tooze, Alexandra Traverse-Glehen, Francisco Vega, Beatrice Vergier, Ashutosh D. Wechalekar, Brent Wood, Luc Xerri, Wenbin Xiao, Norah Olubunmi Akinola, Yassmine Akkari, Luis M. Allende, Katsuyuki Aozasa, Iguaracyra Araujo, Luca Arcaini, Kirit M. Ardeshna, Naoko Asano, Andishe Attarbaschi, Chris M. Bacon, Sharon Louise Barrans, Tracy Batchelor, Maxime Battistella, Linda B. Baughn, Amir Behdad, Sigbjorn Berentsen, Giada Bianchi, Jacob Bledsoe, Peter Borchmann, Mark Bower, Barbara Buldini, Jan Andreas Burger, Birgit Burkhardt, Ryan D. Cassaday, Giovanni Cazzaniga, Nadine Cerf-Bensussan, Ethel Cesarman, Mammen Chandy, Jennifer R. Chapman, Bjorn Chapuy, Xueyan Chen, Chee Leong Cheng, Carlos Chiattone, Nicholas Chiorazzi, Lucy B. Cook, Wendy A. Cooper, Gregory Philip Corboy, Andrew John Cowan, Immacolata Cozzolino, Ian A. Cree, Emanuele S. G. d'Amore, Andrew John Davies, Martina Deckert, Jan Delabie, Elizabeth G. Demicco, Vikram Deshpande, Arjan Diepstra, Daan Dierickx, Kieron Dunleavy, Barbara Eichhorst, Daisuke Ennishi, David C. Fajgenbaum, Pedro Farinha, Carlos Fernandez de Larrea, Kevin E. Fisher, Jude Fitzgibbon, Melina Flanagan, Jonathan Fromm, Juan F. Garcia, William Robert Geddie, Morie Gertz, Ajay Gopal, Satish Gopal, Patricia Theresa Greipp, Alejandro Gru, Ritu Gupta, Martin-Leo Hansmann, Konnie M. Hebeda, Klaus Herfarth, Marco Herling, Olivier Hermine, Khe Hoang-Xuan, Jennelle Hodge, Shimin Hu, Yuhua Huang, Yin Pun Hung, Stephen Hunger, Hiroto Inaba, Hiroshi Inagaki, Javeed Iqbal, Kenji Ishitsuka, Noriko Iwaki, Keiji Iwatsuki, Nitin Jain, Yoon Kyung Jeon, Marshall Kadin, Sachiko Kaji, Aanchal Kakkar, Anastasios Karadimitris, Keisuke Kataoka, Seiichi Kato, Marie Jose Kersten, Rhett P. Ketterling, Ji Eun Kim, Christian P. Kratz, Robert Kridel, Sigurdur Kristinsson, Ralf Kuppers, Isinsu Kuzu, Yok-Lam, Ann Lacasce, Laurence Lamant-Rochaix, Thierry Lamy, Ola Landgren, Siddhartha Laskar, William Bradlyn Laskin, Georg Lenz, Shaoying Li, Gan Di Li, Pei Lin, Franco Locatelli, Robert Brian Lorsbach, Izidore Lossos, Thomas P. Jr Loughran, William R. Macon, Joseph J. Maleszewski, Pankaj Malhotra, Teresa Marafioti, Dai Maruyama, Alexander Marx, Sam M. Mbulaiteye, Veronique Meignin, Ester Mejstrikova, Pamela Michelow, Markku Miettinen, Rodney R. Miles, Hiroaki Miyoshi, Thierry Jo Molina, Manuela Mollejo, Shuji Momose, Tetsuya Mori, William G. Morice, Bertrand Nadel, Hirokazu Nagai, Motoo Nagane, Reena Nair, Naoya Nakamura, Atsuko Nakazawa, Samih Nasr, Andrew Gordon Nicholson, Alina Nicolae, Robert Shigeo Ohgami, Naoki Oishi, Timothy S. Olson, Nicolas Ortonne, Bruno Paiva, Qiang Pan-Hammarstrom, Mayur Parihar, Marco Paulli, Andrea Petersen, Jennifer Picarsic, Alessandro Pileri, Nicola Pimpinelli, Jose A. Plaza, Karen R. Rabin, Markus Raderer, Kanti Rai, Ulla Randen, Huilan Rao, Alistair Robson, Rosemary Rochford, Richard Rosenquist, Davide Rossi, Esther D. Rossi, Simon Rule, Grzegorz Rymkiewicz, Elena Sabattini, Vaskar Saha, Mamiko Sakata-Yanagimoto, Christian A. Sander, J. Martin Sangueza, Omar P. Sangueza, Marco Santucci, Yasuharu Sato, Akira Satou, Kristian Theo Schafernak, Fernando Schmitt, Gianpietro Semenzato, Manju Sengar, Tait Shanafelt, Kazuyuki Shimada, Graham W. Slack, Susan Slager, Riccardo Soffietti, David A. Solomon, Kostas Stamatopoulos, Christian Steidl, Stephan Stilgenbauer, Narittee Sukswai, Kengo Takeuchi, Giovanni Tallini, Junichi Tamaru, Soo-Yong Tan, Prashant Tembhare, Enrico Tiacci, Yoshiki Tokura, Olivier Tournilhac, Steven Treon, Lorenz Truemper, Kunihiro Tsukasaki, Frits van Rhee, Abraham Varghese, Maarten H. Vermeer, Philippe Vielh, Brian Walker, Michael Wang, Huan-You Wang, Zhe Wang, Takashi Watanabe, Oliver Weigert, David Wein-Stock, Sean J. Whittaker, Rein Willemze, Wilhelm Woessmann, Catherine J. Wu, Motoko Yamaguchi, Hidetaka Yamamoto, Daisuke Yamashita, Shenmiao Yang, David T. Yang, Takahiko Yasuda, Wei-Hua Yin, Yoh Zen, Sha Zhao, Wei-Li Zhao

LEUKEMIA (2023)

Add to Collection

Review Pathology

Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside

Paola Francalanci, Barbara Cafferata, Rita Alaggio, Paola de Angelis, Antonella Diamanti, Paola Parente, Massimo Granai, Stefano Lazzi

Summary: Autoimmune enteropathy is a rare disorder characterized by severe diarrhea and malabsorption, mostly affecting infants and young children. It is characterized by villous blunting, crypt hyperplasia, and immune cell infiltration in the small intestine, with the possibility of involvement of the esophagus, stomach, and colon. The presence of anti-enterocyte antibodies aids in diagnosis.

PATHOLOGICA (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.